For over 35 years NATCO has brought wellness to patients in 50+ countries around the world, and since 2006, proudly serving Canadian patients with the same world-class quality of care.
Not resting on its laurels, NATCO is set to scale new heights with an array of new and innovative launches, in several therapeutic areas.
NATCO and its marketing partner Mylan receives final approval of generic Glatiramer Acetate, for both 20 mg/mL and 40 mg/mL versions
Affordable medicine to 50+ countries around the world
Trusted By Canadians
across the Nation